Anti-Viral Drugs Market Analysis and Forecast to 2030 Report

Description

Anti-Viral Drugs Market Report Highlights:

Key Segments: HIV, COVID-19, Viral Hepatitis, Dengue, Oral Drugs, Injectables and Others.

Key Companies: Gilead, Atea Pharmaceuticals, Venatorx, Cocrystal Pharma, inc, AiCuris Anti-infective Cures AG, Abbvie, Boehringer Ingelheim International GmbH., Novartis, Merck & Co., Inc., Pfizer Inc. and Others.

Geographies: USA, China, UK, Japan, Germany, France, Italy, Spain, The Netherlands, Canada, India, South Korea, Australia, New Zealand, Middle East, Africa, South, and Central America

Historical Data: 2018-2020

Forecasting Period: 2021-2030

Research Methods: Primary Research, Secondary Research, COVID-19 Impact Analysis

Forecast Methods: Market Research, Trend Projections, Panel Consensus, Historical Analogy

Pages and Exhibits: 130+ pages, 60+ Statistical Tables, 25+ Analysis Figures

Market Currency: US Dollar ($)

Report Language: English

Report Format: Online, Downloadable PDF, Excel

Available Customizations: Manufacturer Side Report, Distributor Side Report, Thought Leadership Report

Anti-Viral Drugs Market Definition:

In the global anti-viral drugs market, biopharma companies including Gilead, Abbvie, Pfizer, Novartis, among others sell their branded and generic anti-viral drugs to the end users, through distributors, retailers, and other sales channels for the treatment of various viral diseases such as HIV, COVID-19, hepatitis, etc, in the form of oral or injectable administration.

Anti-Viral Drugs Market Segmentation:

Anti-Viral Drugs Market, by Drug class	Branded Generic
Anti-Viral Drugs Market, by Disease	HIV COVID-19 Viral Hepatitis Dengue Influenza Others
Anti-Viral Drugs Market, by Route of Administration	Oral Drugs Injectables
Anti-Viral Drugs Market, By Form	Tablet Capsule Liquid Powder
Anti-Viral Drugs Market, By Customer Group	Hospitals & Clinics Distributors Retailers
Anti-Viral Drugs Market, by Company	Gilead Atea Pharmaceuticals Venatorx Cocrystal Pharma, inc AiCuris Anti-infective Cures AG Abbvie Boehringer Ingelheim International GmbH.  Novartis Merck & Co., Inc.,  Pfizer Inc.  Dr. Reddy’s Laboratories Ltd.  Actiza Pharmaceutical Private Limited Torrent Pharmaceuticals Ltd. Cellvera
Anti-Viral Drugs Market, By Geography	North America USA Canada South and Central America Europe Germany France U.K. Italy Spain The Netherlands Rest of Europe Asia-Pacific China Japan India South Korea Australia New-Zealand Rest of Asia-Pacific Middle East & Africa

Table of Content and Chapter Description:

1. Anti-Viral Drugs Market Summary

This section includes a summary of the whole report. It majorly includes a brief analysis of market numbers, various forecast factors, and market dynamics such as drivers, restraints, opportunities, and key trends. In addition to this, this section also talks about leading players operating in the market.

2. Report Inclusion & Exclusion

This section provides brief idea about the factors included in the study, along with the factors which are not considered in the study. It helps the reader to have better understanding of the provided information.

3. Market Dynamics

This section provides detailed analysis of drivers, restraints, opportunities, and threats which have significant impact on the growth of the market. It also includes key trends influencing the market growth and demand.

4. Key Market Insights

This section majorly includes analysis of micro and macro-economic indicators that would have direct or indirect impact on the market growth. This section also includes pricing analysis, product pipeline analysis, PORTER’S five forces analysis, PESTLE analysis, funding analysis, among others.

5. COVID-19 Impact Analysis

This section provides a detailed analysis of the pre and post-COVID-19 pandemic impact on the market. The section provides the effect of COVID-19 during 2020 and 2021 and also provides a recovery scenario. In addition to this, it also analyzes the impact of the vaccination drive on the market recovery.

6. Anti-Viral Drugs Market Analysis and Forecast to 2030, by Drug class

This section provides detailed country-level market estimations and analysis of Anti-Viral Drugs, by Drug Class. The segments majorly include Branded, Generic, and Others.

7. Anti-Viral Drugs Market Analysis and Forecast to 2030, by Disease

This section provides detailed country-level market estimations and analysis of Anti-Viral Drugs, by Disease. The segments majorly include HIV, COVID-19, Viral Hepatitis, Dengue, Influenza, and Others.

8. Anti-Viral Drugs Market Analysis and Forecast to 2030, by Customer Group

This section provides detailed country-level market estimations and analysis of Anti-Viral Drugs, by Customer Group. The segments majorly include Hospitals & Clinics, Distributors

Retailers, and Others.

9. Anti-Viral Drugs Market Analysis and Forecast to 2030, by Geography

This segmental-level segmental level revenue estimation, forecast and detailed analysis of major geographies including North America, South and Central America, Europe, Asia-Pacific, and Middle East & Africa.

10. Competition Analysis

This section provides detailed analysis of key companies operating in this market. It includes, products/services ranking, market positioning, company competition matrix, impact analysis, market share analysis, and each company’s overviews.

11. Appendix
    • Anti-Viral Drugs Market: Research Methodology

This section includes detailed explanation of various techniques used during market estimation. It majorly involves primary and secondary research. Primary research involves interviews with industry personals and key opinion leaders from respective sectors, while secondary research includes data gathering through internet search, databases such as Bloomberg, FactSet, among others. In addition to this, the section also involves explanation of data forecast models used during the study.

• • Appendix
  • Abbreviations

**Note: Table of Content/ Scope of work subject to change as per client requirements and research updates.